What fluid should be started if a patient's blood glucose is hypoglycemic (low blood sugar)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a patient with a blood sugar level of 10 mg/dL, you should immediately administer intravenous (IV) dextrose, specifically D50W (50% dextrose in water), as the most recent and highest quality study recommends prompt treatment for hypoglycemia 1.

Treatment Approach

The treatment approach for severe hypoglycemia involves administering a concentrated dextrose solution to rapidly increase blood glucose levels.

  • Give 50 mL (25 grams) of D50W as an IV push.
  • If IV access is not available, administer 1 mg of glucagon intramuscularly or subcutaneously while establishing IV access.

Maintenance and Follow-up

After the initial D50W bolus, start an infusion of D10W or D5W to maintain blood glucose levels, typically at 100-150 mL/hour, and check blood glucose every 15-30 minutes until stable.

  • Once the patient is conscious and able to swallow safely, provide oral carbohydrates (juice, glucose tablets, or a small meal) to prevent recurrence.

Importance of Prompt Treatment

This treatment is urgent as severe hypoglycemia (below 40 mg/dL) can rapidly lead to seizures, loss of consciousness, and neurological damage if not corrected quickly, as highlighted in the standards of medical care in diabetes-2022 1.

Key Considerations

  • The brain relies almost exclusively on glucose for energy, making prompt correction of hypoglycemia crucial.
  • The concentrated dextrose solution provides immediate glucose to the bloodstream, which is essential for brain function.
  • Ongoing monitoring and adjustment of treatment are necessary to prevent recurrent hypoglycemia, as recommended in the standards of medical care in diabetes-2020 1.

From the FDA Drug Label

INDICATIONS AND USAGE 50% Dextrose Injection is indicated in the treatment of insulin hypoglycemia (hyperinsulinemia or insulin shock) to restore blood glucose levels. In insulin-induced hypoglycemia, intravenous injection of 10 to 25 grams of dextrose (20 to 50 mL of 50% dextrose) is usually adequate.

The fluid to start if the patient's sugar is down to 10 is 50% Dextrose Injection. The recommended dose is 10 to 25 grams of dextrose (20 to 50 mL of 50% dextrose), which should be administered promptly without awaiting pretreatment test results 2, 2.

From the Research

Treatment of Hypoglycemia

  • The patient's sugar level is down to 10, indicating hypoglycemia, and requires immediate treatment.
  • Studies have compared the effectiveness of 10% dextrose (D10) and 50% dextrose (D50) in treating hypoglycemia 3, 4, 5, 6, 7.

Comparison of D10 and D50

  • Research suggests that D10 may be as effective as D50 in resolving symptoms and correcting hypoglycemia, with fewer adverse events 3, 4.
  • A study found that the median total dose of dextrose administered was significantly less with D10, and median post-treatment blood sugar levels were also significantly lower 4.
  • Another study reported that 100 mL of D10 was effective in treating hypoglycemia, with no reported adverse events or deaths related to D10 administration 5, 6.

Recommendations

  • Based on the studies, D10 may be a suitable alternative to D50 for the treatment of hypoglycemia, especially when considering the potential risks associated with D50, such as extravasation injury and hyperglycemia 3, 4, 5, 6, 7.
  • However, further study is needed to evaluate the use of D10, the need for dextrose readministration, and its impact on clinical outcomes 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.